The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II multi-site investigation of neoadjuvant pembrolizumab and adjuvant concurrent radiation and pembrolizumab with or without cisplatin in resected head and neck squamous cell carcinoma.
 
Trisha Michel Wise-Draper
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; bexion; Bristol-Myers Squibb; Merck; Takeda
 
Matthew O. Old
No Relationships to Disclose
 
Francis P. Worden
Consulting or Advisory Role - Bristol-Myers Squibb; Loxo; Merck
Research Funding - Bristol-Myers Squibb; Eisai (Inst); Merck (Inst); Pfizer (Inst)
 
Paul E. O'Brien
No Relationships to Disclose
 
Ezra E.W. Cohen
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; EMD Serono; Human Longevity, Inc; Merck; Pfizer
 
Neal Dunlap
No Relationships to Disclose
 
Michelle Lynn Mierzwa
No Relationships to Disclose
 
Keith Casper
No Relationships to Disclose
 
Sarah Palackdharry
No Relationships to Disclose
 
Benjamin Hinrichs
No Relationships to Disclose
 
Alfredo Molinolo
No Relationships to Disclose
 
Vinita Takiar
Research Funding - Merck
 
Jonathan Mark
No Relationships to Disclose
 
Alice Tang
No Relationships to Disclose
 
Muhammad Kashif Riaz
No Relationships to Disclose
 
John Charles Morris
Speakers' Bureau - Boehringer Ingelheim; Merck
Travel, Accommodations, Expenses - Amgen; Eisai; EMD Serono; VentiRx
Other Relationship - EMD Serono
 
Nooshin Hashemi Sadraei
Employment - Amgen
 
Changchun Xie
No Relationships to Disclose
 
Maura L. Gillison
Consulting or Advisory Role - Aspyerian Therapeutics; AstraZeneca; Bristol-Myers Squibb; Celgene; EMD Serono; Merck
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst)